HMRC EIS Approved investment – 30% tax relief & 10.3x target ROI – Incredible sector

Published: Mon, 12/09/24

Updated: Sun, 12/15/24

'This is a message from an advertiser. Nothing in this email should be taken as endorsement by MoneyMagpie. Any action taken is at your own risk. Be aware that most investments that produce high returns can also involve significant risk and make sure you are not pressured into buying anything. Check reviews online of any money-making scheme before you try it.'
*|MC:SUBJECT|*
Management team and medical advisory board, with unmatched levels of expertise in key fields.
✔ £24.8m Conservative Growth Profit Forecast - 2029.
✔ £3.36m Conservative Growth Profit Forecast - 2026.
✔ The global breast cancer diagnostics market was valued at USD 4.49 billion in 2023 and is expected to reach over USD 9.00 billion by 2033, poised to grow at a noteworthy CAGR of 7.2% from 2024 to 2033.
✔ With Ai-driven tools and genomic insights, we’re shifting from reactive to proactive cancer care, improving survival rates and patient quality of life, through early detection and precision medicine.
✔ 1 in 8 women will develop breast cancer in their lifetime.*
Click here to learn more
‘ By quantifying circulating tumour cells (CTCs), we can identify early tumour activity in patients. The quantification of CTCs allows us to predict the effectiveness of a chemotherapeutic agent in percentage terms before it is even administered. That means we know how many cells will be killed in each round of therapy. We are developing a new platform-based solution to CTC cell counting for routine medical diagnostics. ’

Dr. Martin Burow CEO, The former Head of Asia Pacific for Thermo Fisher
EIS TAX Benefits for Investors
✔ 30% Income Tax Relief.
✔ 0% Capital Gains Tax.
✔ IHT Tax Exempt.
✔ Tax Loss Relief.
✔ CGT Deferral Relief.
Click here to learn more
* https://amp.cancer.org
Disclaimer: Any person accessing the email and considering potential investment opportunities featured on the email should make their own commercial assessment of an investment opportunity after seeking the advice of an appropriately authorised or regulated financial advisor. This email should not be construed as advice or a personal recommendation to any prospective investor.
 
This is your free email newsletter from MoneyMagpie.com, the site that helps you take control of your finances and build a richer life.

MoneyMagpie
22 Pembridge Gardens
Notting Hill London W2 4DX
UNITED KINGDOM

Unsubscribe   |   Change Subscriber Options